Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 449.20
+2.40 (0.54%)
At close: Oct 15, 2026
Renata Market Cap
Renata has a market cap or net worth of 51.52 billion as of October 15, 2026. It is the 16,005th most valuable company in the world and the 14th biggest in Bangladesh. Its market cap has decreased by 3.38% in one year.
Market Cap
51.52B
Enterprise Value
69.40B
Revenue
44.93B
Global Rank
Country Rank
#14 Bangladesh
PE Ratio
18.77
ChartMarket Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 51.52B, an increase of 15,961.79%. That is a compound annual growth rate of 24.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 51.52B | 14.65% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 194.66B |
| Beximco Pharmaceuticals PLC. | 64.64B |
| Unilever Consumer Care | 38.12B |
| Beacon Pharmaceuticals | 23.26B |
| The ACME Laboratories | 16.29B |
| Asiatic Laboratories | 12.64B |
| The IBN SINA Pharmaceutical Industry | 9.63B |
| Navana Pharmaceuticals | 6.72B |